We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Law Firm Pushes FDA to Rethink Restrictions on Meetings With Senior Staff
Law Firm Pushes FDA to Rethink Restrictions on Meetings With Senior Staff
A law firm that represents drugmakers is urging the FDA to rethink its stance on granting meetings with senior FDA officials, saying the agency’s policy can imperil drug research.